Support@AnalyticaNow.net
Let's Talk:(617) 657-4975
  • Bookmarks
    • Add bookmark
Group@0.5x-Blue-AlignedGroup@0.5x-Blue-Aligned
Health Analytics, Economics, Policy
  • Home
  • Services
    • Program Design & Evaluation
    • Economic Analysis
    • Return on Investment Analysis
    • Clinical Data Analytics
    • Other Services
  • Insights
    • View Insights Here
    • Subscribe Our Newsletter
  • Data Security
  • About
  • Appointment
Group@0.5x-Blue-Aligned
Health Analytics, Economics, Policy
Close
  • Home
  • Services
    • Program Design & Evaluation
    • Economic Analysis
    • Return on Investment Analysis
    • Clinical Data Analytics
    • Other Services
  • Insights
    • View Insights Here
    • Subscribe Our Newsletter
  • Data Security
  • About
  • Appointment
Client login
Forgot password?
You can login using your social profile
Paste the shortcode from one of the relevant plugins here in order to enable logging in with social networks.

Great Disappointment: Some Policymakers Ignore Basic Economics in Drafting Prescription Drug Pricing Policies

Posted August 23, 2022 0 0
Great Disappointment: Some Policymakers Ignore Basic Economics in Drafting Prescription Drug Pricing Policies

Last week, the U.S. Senate leaders started efforts in reviving the Build Back Better bill, including Medicare prescription drug price regulations. The main provision is to allow Medicare to negotiate drug prices directly with manufacturers for up...

Read more

Regulating Pharmacy Benefit Managers’ Rebate Practices: Are We Barking Up the Wrong Tree?

Posted August 23, 2022 0 0
Regulating Pharmacy Benefit Managers’ Rebate Practices: Are We Barking Up the Wrong Tree?

On June 7, the Federal Trade Commission (FTC) launched “an inquiry into the prescription drug middleman industry,” seeking documentation and records of business practices from the six largest pharmacy benefit managers (PBM). The goal is to...

Read more

Medication Subscription Model Unlikely To Reduce Cost Drastically

Posted October 24, 2021 0 1
Medication Subscription Model Unlikely To Reduce Cost Drastically

In June 2019, Louisiana contracted with Asegua Therapeutics––a subsidiary of Gilead Sciences––to pay a lump sum in exchange for as much of a new hepatitis C regimen as is needed to treat patients in its Medicaid program and correction facilities...

Read more
Search
Publications by Topic
  • Emerging Business Models
  • Emerging Care Models
  • Employer-Sponsored Insurance
  • Health Insurance
  • Healthcare Innovation
  • Healthcare Policy
  • Medical Device Innovation
  • Mental Health Policy
  • Prescription Drug Policy
  • Program Evaluation
  • Value-Based Care
Recent Publications
How Much Medical Costs Can We Bear? There is a Number for it
How Much Medical Costs Can...
January 9, 20230
The Most Promising Value-Based Model in the Commercial Market: the Lean Value Model
The Most Promising...
January 9, 20230
Calendar
November
SMTWTFS
 1234
567891011
12131415161718
19202122232425
2627282930 
Group@0.5x-white
Health Analytics, Economics, Policy
Analytica Now is an analyst you can trust. We are an analyst that makes our clients feel confident in their results. A sense of trust and assurance can become especially important as we make tough decisions. Our care in analytics helps you ease these challenges and enables you to enjoy doing what you do!
Contact Us
1309 Beacon St, Suite 300
Brookline, MA 02446

Tel: (617) 657-4975

Email: Support@AnalyticaNow.net
Follow Us
  • Home
  • Services
  • Insights
  • About Us
  • Data Security
  • Appointment
Analytica Now LLC © 2023. All rights reserved.